San Diego – January 11, 2017 – Cooley advised the initial purchasers on NantHealth’s $107 million offering of aggregate principal amount of 5.50% convertible senior notes due 2021, including a separate concurrent $10 million private placement and $7 million of option notes.

JP Morgan and Jefferies acted as joint book-running managers for the offering, Cowen and Company acted as lead manager and Canaccord Genuity acted as co-manager.

NantHealth, which trades on the NASDAQ Global Select Market under the symbol “NH,” is a next generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses.

Cooley previously advised the underwriters on NantHealth’s $97 million IPO.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.